Seastar Medical Hldg Corp (ICU)

$3.34 +0.09 (2.77%)
Market Cap 14.32M
Revenue (ttm) 1.23M
Net Income (ttm) -12.15M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -987.80%
Debt to Equity Ratio 0.00
Volume 30,400
Avg Vol 93,396
Day's Range N/A - N/A
Shares Out 4.41M
Stochastic %K 39%
Beta -1.05
Analysts Strong Sell
Price Target $10.00

Company Profile

SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 427 8100
Address:
3513 Brighton Boulevard, Suite 410, Denver, United States
BULLISH1975
BULLISH1975 Aug. 19 at 2:42 AM
$ICU i like this!! ‘Eric Schlorf, CEO: We evaluate all other applications, but as a company, we must stay focused on Qualimmune for pediatric AKI and the Neutralize-AKI trial for adults. We have the NIH-funded Neutralize-CRS study and are in discussions with various parties, including non-dilutive and strategic business development opportunities, to advance other pipeline indications. Dr. Kevin Chung added that the Neutralize-AKI trial uses block randomization to ensure equal distribution of patients with ARDS and sepsis, allowing us to make specific statements about those subpopulations.’ lots in this above paragraph!!! dyor
1 · Reply
BULLISH1975
BULLISH1975 Aug. 19 at 2:39 AM
$ICU from earning call ‘What is the status of the SAVE registry and the ICD-10 PCS codes?A: Tim Varacek, SVP of Commercial and Business Operations: We have completed the 50-patient SAVE registry required by the FDA, submitted the preliminary report, and are preparing the final report for FDA review. Results from the first 21 patients were published in the peer-reviewed journal Pediatric Nephrology. Additionally, CMS assigned ICD-10 PCS codes for our SCD therapy, which will be implemented on October 1st of this year. ‘ ****preparing final report for FDA review
1 · Reply
BULLISH1975
BULLISH1975 Aug. 19 at 2:34 AM
$ICU from Earning call!! ‘Q: What work is being done behind the scenes on other indications for the SCD therapy, such as ARDS, hepatorenal syndrome, or cardiorenal syndrome?A: Eric Schlorf, CEO: We evaluate all other applications, but as a company, we must stay focused on Qualimmune for pediatric AKI and the Neutralize-AKI trial for adults. We have the NIH-funded Neutralize-CRS study and are in discussions with various parties, including non-dilutive and strategic business development opportunities, to advance other pipeline indications’ ****discussions with various parties , including non dilutive…. Lots going in here shareholders dyor
0 · Reply
SparkyReturns
SparkyReturns Aug. 19 at 1:41 AM
$ICU I just watched the webinar. Excellent. Looks like the earlier that the doctors prescribe it, the higher chance of success. And for those of you that don’t have time to watch it, they had one case where a girl had a severe case of malaria, with AKI and sepsis, and didn’t have a very good chance to make it, and with the SCD she had a total recovery.Amazing.
2 · Reply
Aznwactrackstar
Aznwactrackstar Aug. 19 at 1:32 AM
$ICU 👀
0 · Reply
BULLISH1975
BULLISH1975 Aug. 19 at 1:04 AM
$ICU the doctors and nurses here must be VERY confident in the SCD device results AND mgt to speak out about this device!!!!! dyor
0 · Reply
sideload
sideload Aug. 19 at 12:39 AM
$ICU
0 · Reply
sideload
sideload Aug. 19 at 12:36 AM
$ICU added 500 Monday at $3.20 You know that the save is getting filed with 90 day data. No such thing as a gaurantee but it’s a beans and rice no brainer that the FDA will love it. How long will it take ? - that’s the question. Buy on any significant dip as an explosion of interest and price is coming and when it does I suspect we get a private placement at a decent price and we’re in a slow motion wave headed for the promise land.
1 · Reply
Yi_YandH
Yi_YandH Aug. 18 at 11:21 PM
$ICU Every prestigious Adult & Children’s Nephrology department from this nation’s top higher learning institutions and many top hospital nephrologists cite positive results and are onboard with. One year later and………. 20 customers with the right —- —answer. 20 healing enterprises have made the right —-decision. ————————Wow. Wow. Wow.———————— Faith, by the OGs here is a powerful force. The science is solid, as a rock! -Unfortunately the medical system in America is controlled by the multi-billion $ private insurance corporations and the high dollar: ‘It’s still just too risky’ liability law firms. -Hospital administrators need to recognize that lives are passing and many kids are suffering needlessly. -Man or Woman up already FFS! Fin. https://karger.com/bpu/article-pdf/55/2/107/4456545/000549111.pdf
1 · Reply
Yi_YandH
Yi_YandH Aug. 18 at 11:00 PM
$ICU @BSL6356 WHEN JW, WHEN?
0 · Reply
Latest News on ICU
SeaStar Medical Holding Earnings Call Transcript: Q2 2026

Aug 12, 2026, 4:30 PM EDT - 6 days ago

SeaStar Medical Holding Earnings Call Transcript: Q2 2026

SeaStar Medical Holding Earnings release: Q2 2026

Aug 12, 2026, 4:30 PM EDT - 6 days ago

SeaStar Medical Holding Earnings release: Q2 2026

SeaStar Medical Holding Quarterly report: Q2 2026

Aug 12, 2026, 4:30 PM EDT - 6 days ago

SeaStar Medical Holding Quarterly report: Q2 2026

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Aug 12, 2026, 4:05 PM EDT - 6 days ago

SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

Aug 6, 2026, 8:35 AM EDT - 12 days ago

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

Jul 14, 2026, 8:34 AM EDT - 5 weeks ago

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

SeaStar Medical Holding Transcript: Investor Summit Virtual Conference

Jun 24, 2026, 10:30 AM EDT - 7 weeks ago

SeaStar Medical Holding Transcript: Investor Summit Virtual Conference

SeaStar Medical announces new CD-10-PCS codes for SCD therapy

2026-06-23T16:34:58.000Z - 2 months ago

SeaStar Medical announces new CD-10-PCS codes for SCD therapy

SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury

Jun 23, 2026, 8:25 AM EDT - 2 months ago

SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury

SeaStar Medical to Present at Upcoming Investor Summit Conference

Jun 22, 2026, 8:45 AM EDT - 2 months ago

SeaStar Medical to Present at Upcoming Investor Summit Conference

SeaStar Medical price target raised to $8 from $6 at Maxim

2026-05-14T14:34:45.000Z - 3 months ago

SeaStar Medical price target raised to $8 from $6 at Maxim

SeaStar Medical Holding Earnings Call Transcript: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

SeaStar Medical Holding Earnings Call Transcript: Q1 2026

SeaStar Medical Holding Earnings release: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

SeaStar Medical Holding Earnings release: Q1 2026

SeaStar Medical Holding Quarterly report: Q1 2026

May 13, 2026, 4:30 PM EDT - 3 months ago

SeaStar Medical Holding Quarterly report: Q1 2026

SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

May 13, 2026, 4:05 PM EDT - 3 months ago

SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

SeaStar Medical Holding Registration statement: Registration filing

May 7, 2026, 8:00 AM EDT - 3 months ago

SeaStar Medical Holding Registration statement: Registration filing

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

May 6, 2026, 8:20 AM EDT - 3 months ago

SeaStar Medical to Report First Quarter Financial Results on May 13, 2026

SeaStar Medical Holding Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 3 months ago

SeaStar Medical Holding Proxy statement: Proxy filing

SeaStar Medical Holding Registration statement: Registration filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

SeaStar Medical Holding Registration statement: Registration filing

SeaStar Medical showcases new data from SAVE Registry

2026-03-30T13:27:26.000Z - 5 months ago

SeaStar Medical showcases new data from SAVE Registry

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

Mar 30, 2026, 8:20 AM EDT - 5 months ago

SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026

SeaStar Medical Holding Earnings Call Transcript: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 5 months ago

SeaStar Medical Holding Earnings Call Transcript: Q4 2025

SeaStar Medical Holding Annual report: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 5 months ago

SeaStar Medical Holding Annual report: Q4 2025

SeaStar Medical Holding Earnings release: Q4 2025

Mar 25, 2026, 4:30 PM EDT - 5 months ago

SeaStar Medical Holding Earnings release: Q4 2025

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Mar 25, 2026, 4:05 PM EDT - 5 months ago

SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

Mar 18, 2026, 4:05 PM EDT - 5 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

SeaStar Medical Holding Transcript: Life Sciences Virtual Investor Forum

Mar 11, 2026, 12:00 PM EDT - 5 months ago

SeaStar Medical Holding Transcript: Life Sciences Virtual Investor Forum

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

Mar 9, 2026, 8:35 AM EDT - 5 months ago

SeaStar Medical to Present at the Life Sciences Investor Forum on March 11th

SeaStar Medical completes FDA enrollment requirement for SAVE Registry

2026-03-05T13:36:45.000Z - 5 months ago

SeaStar Medical completes FDA enrollment requirement for SAVE Registry

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

Mar 5, 2026, 8:20 AM EST - 5 months ago

SeaStar Medical Announces Completion of FDA Enrollment Requirement for SAVE Surveillance Registry Evaluating QUELIMMUNE Safety for Pediatric AKI

SeaStar Medical price target lowered to $6 from $10 at Maxim

2026-02-12T14:06:17.000Z - 6 months ago

SeaStar Medical price target lowered to $6 from $10 at Maxim

SeaStar Medical reports ‘strong’ survival data in Quelimmune study

2026-02-09T13:25:53.000Z - 6 months ago

SeaStar Medical reports ‘strong’ survival data in Quelimmune study

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

Feb 9, 2026, 8:20 AM EST - 6 months ago

SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI)

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

Jan 29, 2026, 8:25 AM EST - 7 months ago

SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference

SeaStar Medical Holding Transcript: Biotech Showcase 2026

Jan 13, 2026, 6:00 PM EST - 7 months ago

SeaStar Medical Holding Transcript: Biotech Showcase 2026

SeaStar Medical Holding Slides: Investor presentation

Jan 9, 2026, 7:00 AM EST - 7 months ago

SeaStar Medical Holding Slides: Investor presentation

SeaStar Medical announces 2026 milestones

2026-01-07T13:21:08.000Z - 7 months ago

SeaStar Medical announces 2026 milestones

SeaStar Medical Announces 2026 Milestones

Jan 7, 2026, 8:13 AM EST - 7 months ago

SeaStar Medical Announces 2026 Milestones

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

Jan 6, 2026, 8:53 AM EST - 8 months ago

SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference

SeaStar Medical Holding Corp trading halted, news pending

2026-01-03T00:50:17.000Z - 8 months ago

SeaStar Medical Holding Corp trading halted, news pending

SeaStar Medical announces 1-for-10 reverse stock split

2025-12-23T21:30:17.000Z - 8 months ago

SeaStar Medical announces 1-for-10 reverse stock split

SeaStar Medical Announces 1-for-10 Reverse Split

Dec 23, 2025, 4:25 PM EST - 8 months ago

SeaStar Medical Announces 1-for-10 Reverse Split

SeaStar reports approval for reduction in mandatory enrollment for SAVE registry

2025-12-02T13:30:31.000Z - 9 months ago

SeaStar reports approval for reduction in mandatory enrollment for SAVE registry

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

Dec 2, 2025, 8:27 AM EST - 9 months ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

Nov 20, 2025, 9:52 AM EST - 9 months ago

SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference

SeaStar Medical appoints Michael Messinger as CFO

2025-11-17T13:50:19.000Z - 9 months ago

SeaStar Medical appoints Michael Messinger as CFO

SeaStar Medical Announces Appointment of Michael Messinger as CFO

Nov 17, 2025, 8:43 AM EST - 9 months ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

SeaStar Medical Holding Proxy statement: Proxy Filing

Nov 14, 2025, 7:00 AM EST - 9 months ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

SeaStar Medical Holding Earnings Call Transcript: Q3 2025

SeaStar Medical Holding Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

SeaStar Medical Holding Quarterly report: Q3 2025

SeaStar Medical Holding Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

SeaStar Medical Holding Earnings release: Q3 2025

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 13, 2025, 4:05 PM EST - 9 months ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

Nov 5, 2025, 10:03 AM EST - 10 months ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

SeaStar Medical Holding Proxy statement: Proxy Filing

Nov 4, 2025, 7:00 AM EST - 10 months ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical announces preliminary results from SAVE Surveillance Registry

2025-09-29T13:00:23.000Z - 11 months ago

SeaStar Medical announces preliminary results from SAVE Surveillance Registry

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Sep 29, 2025, 8:36 AM EDT - 11 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Why Is SeaStar Medical Stock (ICU) Down 45% Today?

2025-09-25T13:24:14.000Z - 11 months ago

Why Is SeaStar Medical Stock (ICU) Down 45% Today?

Review board recommends SeaStar Medical continue with NEUTRALIZE-AKI trial

2025-09-24T20:40:35.000Z - 11 months ago

Review board recommends SeaStar Medical continue with NEUTRALIZE-AKI trial

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Sep 24, 2025, 4:22 PM EDT - 11 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

Sep 23, 2025, 8:23 AM EDT - 11 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

SeaStar Medical Holding Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 7:00 AM EDT - 1 year ago

SeaStar Medical Holding Transcript: H.C. Wainwright 27th Annual Global Investment Conference

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 6:13 PM EDT - 1 year ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

SeaStar Medical announces newly published QUELIMMUNE therapy

2025-09-02T12:45:53.000Z - 1 year ago

SeaStar Medical announces newly published QUELIMMUNE therapy

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

Sep 2, 2025, 8:22 AM EDT - 1 year ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

SeaStar Medical Holding Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q2 2025

SeaStar Medical Holding Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Quarterly report: Q2 2025

SeaStar Medical Holding Earnings release: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q2 2025

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 13, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical files to sell 10.92M shares of common stock for holders

2025-08-08T21:10:33.000Z - 1 year ago

SeaStar Medical files to sell 10.92M shares of common stock for holders

SeaStar Medical Holding Registration statement: Registration Filing

Aug 8, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

Aug 7, 2025, 10:00 AM EDT - 1 year ago

SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025

SeaStar Medical reaches new enrollment milestone in NEUTRALIZE-AKI trial

2025-08-06T12:42:53.000Z - 1 year ago

SeaStar Medical reaches new enrollment milestone in NEUTRALIZE-AKI trial

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

Aug 6, 2025, 8:33 AM EDT - 1 year ago

SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI)

SeaStar Medical announces $4.4M registered direct offering priced at-the-market

2025-07-31T19:10:42.000Z - 1 year ago

SeaStar Medical announces $4.4M registered direct offering priced at-the-market

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 31, 2025, 3:01 PM EDT - 1 year ago

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

Jul 22, 2025, 8:20 AM EDT - 1 year ago

SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Jul 16, 2025, 8:45 AM EDT - 1 year ago

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 10, 2025, 3:29 PM EDT - 1 year ago

SeaStar Medical Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

Jul 8, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)

SeaStar Medical Announces Positive Nasdaq Listing Determination

Jul 2, 2025, 4:25 PM EDT - 1 year ago

SeaStar Medical Announces Positive Nasdaq Listing Determination

SeaStar Medical Reports Update on Nasdaq Listing Status

Jun 25, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Reports Update on Nasdaq Listing Status

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

Jun 24, 2025, 9:05 AM EDT - 1 year ago

SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

Jun 20, 2025, 12:10 PM EDT - 1 year ago

SeaStar Medical Announces Pricing of Up to $8 Million Public Offering

SeaStar Medical Holding Registration statement: Registration Filing

Jun 20, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical Holding Registration statement: Registration Filing

Jun 16, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

Jun 11, 2025, 8:25 AM EDT - 1 year ago

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical's SCD Therapy to Advance Breakthrough Burn and Sepsis Research

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

May 28, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CMS Coverage for Medicare and Medicaid Eligible Patients with Cardiorenal Syndrome Awaiting LVAD in Investigational Trial of SCD Therapy

SeaStar Medical Holding Slides: Investor Presentation

May 20, 2025, 7:00 AM EDT - 1 year ago

SeaStar Medical Holding Slides: Investor Presentation

SeaStar Medical Holding Registration statement: Registration Filing

May 19, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

SeaStar Medical Holding Earnings Call Transcript: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q1 2025

SeaStar Medical Holding Quarterly report: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Quarterly report: Q1 2025

SeaStar Medical Holding Earnings release: Q1 2025

May 14, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q1 2025

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

May 14, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

May 13, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

May 7, 2025, 10:00 AM EDT - 1 year ago

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

SeaStar Medical Holding Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Proxy statement: Proxy Filing

May 6, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

Apr 30, 2025, 8:05 AM EDT - 1 year ago

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

SeaStar Medical Holding Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Registration statement: Registration Filing

Apr 22, 2025, 8:00 AM EDT - 1 year ago

SeaStar Medical Holding Registration statement: Registration Filing

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Apr 8, 2025, 8:05 AM EDT - 1 year ago

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

SeaStar Medical Holding Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings Call Transcript: Q4 2024

SeaStar Medical Holding Annual report: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Annual report: Q4 2024

SeaStar Medical Holding Earnings release: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

SeaStar Medical Holding Earnings release: Q4 2024

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 27, 2025, 4:05 PM EDT - 1 year ago

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

Mar 24, 2025, 5:30 PM EDT - 1 year ago

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Mar 18, 2025, 8:45 AM EDT - 1 year ago

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

SeaStar Medical Holding Proxy statement: Proxy Filing

Mar 4, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Proxy statement: Proxy Filing

Feb 28, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Holding Proxy statement: Proxy Filing

Feb 18, 2025, 7:00 AM EST - 1 year ago

SeaStar Medical Holding Proxy statement: Proxy Filing

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

Feb 3, 2025, 4:05 PM EST - 1 year ago

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

BULLISH1975
BULLISH1975 Aug. 19 at 2:42 AM
$ICU i like this!! ‘Eric Schlorf, CEO: We evaluate all other applications, but as a company, we must stay focused on Qualimmune for pediatric AKI and the Neutralize-AKI trial for adults. We have the NIH-funded Neutralize-CRS study and are in discussions with various parties, including non-dilutive and strategic business development opportunities, to advance other pipeline indications. Dr. Kevin Chung added that the Neutralize-AKI trial uses block randomization to ensure equal distribution of patients with ARDS and sepsis, allowing us to make specific statements about those subpopulations.’ lots in this above paragraph!!! dyor
1 · Reply
BULLISH1975
BULLISH1975 Aug. 19 at 2:39 AM
$ICU from earning call ‘What is the status of the SAVE registry and the ICD-10 PCS codes?A: Tim Varacek, SVP of Commercial and Business Operations: We have completed the 50-patient SAVE registry required by the FDA, submitted the preliminary report, and are preparing the final report for FDA review. Results from the first 21 patients were published in the peer-reviewed journal Pediatric Nephrology. Additionally, CMS assigned ICD-10 PCS codes for our SCD therapy, which will be implemented on October 1st of this year. ‘ ****preparing final report for FDA review
1 · Reply
BULLISH1975
BULLISH1975 Aug. 19 at 2:34 AM
$ICU from Earning call!! ‘Q: What work is being done behind the scenes on other indications for the SCD therapy, such as ARDS, hepatorenal syndrome, or cardiorenal syndrome?A: Eric Schlorf, CEO: We evaluate all other applications, but as a company, we must stay focused on Qualimmune for pediatric AKI and the Neutralize-AKI trial for adults. We have the NIH-funded Neutralize-CRS study and are in discussions with various parties, including non-dilutive and strategic business development opportunities, to advance other pipeline indications’ ****discussions with various parties , including non dilutive…. Lots going in here shareholders dyor
0 · Reply
SparkyReturns
SparkyReturns Aug. 19 at 1:41 AM
$ICU I just watched the webinar. Excellent. Looks like the earlier that the doctors prescribe it, the higher chance of success. And for those of you that don’t have time to watch it, they had one case where a girl had a severe case of malaria, with AKI and sepsis, and didn’t have a very good chance to make it, and with the SCD she had a total recovery.Amazing.
2 · Reply
Aznwactrackstar
Aznwactrackstar Aug. 19 at 1:32 AM
$ICU 👀
0 · Reply
BULLISH1975
BULLISH1975 Aug. 19 at 1:04 AM
$ICU the doctors and nurses here must be VERY confident in the SCD device results AND mgt to speak out about this device!!!!! dyor
0 · Reply
sideload
sideload Aug. 19 at 12:39 AM
$ICU
0 · Reply
sideload
sideload Aug. 19 at 12:36 AM
$ICU added 500 Monday at $3.20 You know that the save is getting filed with 90 day data. No such thing as a gaurantee but it’s a beans and rice no brainer that the FDA will love it. How long will it take ? - that’s the question. Buy on any significant dip as an explosion of interest and price is coming and when it does I suspect we get a private placement at a decent price and we’re in a slow motion wave headed for the promise land.
1 · Reply
Yi_YandH
Yi_YandH Aug. 18 at 11:21 PM
$ICU Every prestigious Adult & Children’s Nephrology department from this nation’s top higher learning institutions and many top hospital nephrologists cite positive results and are onboard with. One year later and………. 20 customers with the right —- —answer. 20 healing enterprises have made the right —-decision. ————————Wow. Wow. Wow.———————— Faith, by the OGs here is a powerful force. The science is solid, as a rock! -Unfortunately the medical system in America is controlled by the multi-billion $ private insurance corporations and the high dollar: ‘It’s still just too risky’ liability law firms. -Hospital administrators need to recognize that lives are passing and many kids are suffering needlessly. -Man or Woman up already FFS! Fin. https://karger.com/bpu/article-pdf/55/2/107/4456545/000549111.pdf
1 · Reply
Yi_YandH
Yi_YandH Aug. 18 at 11:00 PM
$ICU @BSL6356 WHEN JW, WHEN?
0 · Reply
Yi_YandH
Yi_YandH Aug. 18 at 10:58 PM
$ICU NOW?
0 · Reply
Yi_YandH
Yi_YandH Aug. 18 at 10:34 PM
$ICU
0 · Reply
RJLeonii
RJLeonii Aug. 18 at 9:38 PM
$ICU Another 4000 shares about to be gobbled up! New hospitals being added every quarter. Revenues picking up steam Cash burn coming down. ICD -10 codes effective October 1st. Keep saving lives!
0 · Reply
local42r
local42r Aug. 18 at 9:20 PM
$ICU Huge sell-off after hour. Less than 3 hundred shares. Child molesters, playing with it.
0 · Reply
BULLISH1975
BULLISH1975 Aug. 18 at 8:15 PM
$ICU our chart will look like $AMLX in a few months and years!!!! phase III full enrollment end of 2026/2027. TAM billions same device SCD already FDA HDE approved and saving lives! if you watch the link below you will be loading ICU Seastar Medical dyor float 4 million shares gross margins over 90% 5 breakthrough device destinations
0 · Reply
local42r
local42r Aug. 18 at 8:03 PM
$ICU There you have it, Closed green as a frog 🐸. It's 🐸 season again.
0 · Reply
BULLISH1975
BULLISH1975 Aug. 18 at 7:47 PM
$ICU for those with time!!!! well worth the listen! This company is a gift at this SP!!!!$ENSC
0 · Reply
Yi_YandH
Yi_YandH Aug. 18 at 6:06 PM
$ICU There is a possibility that a sweet piece of property will selland close before SeaStar reaches $10 PPS. If so… I will be buying 2500-3500 shares for myself and 500 shares for each of my 3 daughters. Rock on. 🤘 Peace, love and togetherness.
0 · Reply
CanadianDreamcast
CanadianDreamcast Aug. 18 at 2:08 PM
$ICU I'd rather Schlorff dilute a little every month then rip the band aide off under $1. He's learning
0 · Reply
Capitalistpig57
Capitalistpig57 Aug. 18 at 1:59 PM
$ICU
0 · Reply
BottomUp00
BottomUp00 Aug. 18 at 1:58 PM
$ICU
0 · Reply
Yi_YandH
Yi_YandH Aug. 18 at 1:44 PM
$ICU This company’s AKI quick detection test will be SOC for emergency department patient here in the USA soon. The pediatric test is already available. The adult test is in validation trials here currently. Our CMO believes that it will be the test that precedes the prescription of the SCD. Rock on. https://bioporto.com/
1 · Reply